Education
About Us
Working with TipRanks
Follow Us
Thomas Chorman Insider Profile
4 Followers
Thomas Chorman, Director at Standex International, holds 13.23K shares in Standex International (Ticker: SXI), holds 63.65K shares in Symmetry Medical (Ticker: ~SMA). Most recently, Thomas Chorman Sold ― shares of Standex International on Nov 24, 2025 for an estimated value of $223.31K.
Profitable Transactions
4 out of 12 Profitable Transactions
Average Return
-1.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Thomas Chorman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 22, 2018 - May 22, 2019
Return:+30.40%
The most profitable trade made by Thomas Chorman
Thomas Chorman's Trading History
Standex International
Nov 24, 2025
Director
Informative Sell
223.31K
$2.93M
Symmetry Medical
Apr 09, 2012
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Thomas Chorman's performance on stock
You May Also Like
Thomas Chorman insider profile FAQ
What is the percentage of profitable transactions made by Thomas Chorman?
The percentage of profitable transactions made by Thomas Chorman is 33%.
What is the average return per transaction made by Thomas Chorman?
The average return per transaction made by Thomas Chorman is -1.90%.
What stocks does Thomas Chorman hold?
Thomas Chorman holds: SXI, ~SMA stocks.
What was Thomas Chorman’s latest transaction?
Thomas Chorman latest transaction was an Informative Sell of $223.31K.
What was Thomas Chorman's most profitable transaction?
Thomas Chorman’s most profitable transaction was an Informative Sell of SXI stock on May 22, 2018. The return on the trade was 30.40%.
What is Thomas Chorman's role in Standex International?
Thomas Chorman's role in Standex International is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.